paradigmnt10q093008.htm
SECURITIES
AND EXCHANGE COMMISSION
WASHINGTON,
DC 20549
FORM
12b-25
NOTIFICATION
OF LATE FILING
Commission
File Number 0-28498
(Check
one)
|_| Form
10-K and Form 10-KSB |_| Form 11-K
|_| Form
20-F |X| Form 10-Q and Form 10-QSB |_| Form
N-SAR
For
period ended: September 30, 2008
|_|
Transition Report on Form 10-K and Form 10-KSB
|_|
Transition Report on Form 20-F
|_|
Transition Report on Form 11-K
|_|
Transition Report on Form 10-Q and Form 10-QSB
|_|
Transition Report on Form N-SAR
For the
transition period ended
_____________________________________________
Read
Attached Instruction Sheet Before Preparing Form. Please Print or
Type.
Nothing
in this form shall be construed to imply that
the Commission has verified
any information contained herein.
If
the notification relates to a portion of
the filing checked above, identify
the item(s) to which the notification relates______________________
PART
I
REGISTRANT
INFORMATION
Full name
of registrant: Paradigm Medical Industries, Inc.
Former
name if applicable:
Address
of principal executive office (Street and number):
2355
South 1070 West
Salt Lake
City, Utah 84119
PART
II
RULE
12b-25(b) AND (c)
If
the subject report could not be
filed without unreasonable effort or
expense and
the registrant seeks relief pursuant to
Rule 132b-25(b), the
following
should be completed. (Check box if appropriate).
(a) The
reasons described in reasonable detail in Part III of this form
could not be
eliminated without unreasonable effort
or
expense.
|X|
(b) The
subject annual report, semi-annual report, transition
report on
Form 10-K, Form 20-F, 11-K or Form N-SAR, or portion thereof,
will be filed on or before the fifteenth calendar day
following the prescribed due date; or the
subject quarterly report
of transition report on Form 10-Q, or
portion thereof will be
filed on or before the
fifth calendar day following the
prescribed due date; and
(c) The accountant's statement
or other exhibit required by Rule
12(b)-25(c) has been attached if applicable.
PART
III
NARRATIVE
State
below in reasonable detail
the reasons why Forms 10-K, 11-K, 10-Q, N-SAR
or the transition report or
portion thereof, could not be filed within
the prescribed time period. (Attach extra sheets if needed.)
The
Form 10-Q cannot be completed within the prescribed time period due to the
additional time required because of complexities involved in
completing
the
required financial statements, especially in complying with the disclosure
requirements
of Statement of Financial Accounting Standards No. 133, Accounting
for
Derivative Instruments and Hedging Activities, which was issued by the
Financial
Accounting Standards Board.
PART
IV
OTHER
INFORMATION
(1) Name
and telephone number of person to contact in
regard to this notification
Randall
A.
Mackey (801) 575-5000
----------------- ----------- ------------------
(name)
(area code) (telephone
number)
(2) Have
all other periodic reports required under Section 13 or
15(d) of the
Securities Exchange Act of 1934 or Section 30 of the Investment
Company Act
of 1940
during the preceding 12 months (or for
such shorter) period that the registrant was required
to file such report(s) been filed? If answer is
no, identify
report(s).
|X|
Yes |_| No
(3) Is
it anticipated that any significant change in results of operations
from the
corresponding period for the last fiscal year will be reflected by
the earnings
statements to be included in the subject report or portion thereof?
If so,
attach an explanation of
the anticipated change, both narratively
and quantitatively,
and, if appropriate, state the reasons why a reasonable estimate
of the
results cannot be made.
|_|
Yes |X| No
Paradigm
Medical Industries, Inc.
----------------------------------
(Name of
Registrant as Specified in Charter)
Has caused this notification to
be signed on its behalf by the undersigned hereunto
duly authorized.
Date: November
17, 2008
|
By:
/s/ Luis A. Mostacero
|
|
-------------------------------------
|
|
Luis
A. Mostacero
|
|
Vice
President of Finance,
|
|
Chief
Financial Officer,
|
|
Treasurer
and Secretary
|